Report Detail

Request for Sample of this report

Other Global Chronic Thromboembolic Pulmonary Hypertension Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4598270
    • |
  • 02 July, 2024
    • |
  • Global
    • |
  • 106 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Chronic Thromboembolic Pulmonary Hypertension market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Chronic thromboembolic pulmonary hypertension is observed to be one of the leading causes of severe pulmonary hypertension. It is a type of clinical condition in which pulmonary vascular resistance increases giving rise to pulmonary hypertension and progressive heart failure. According to World Health Organization (WHO), approximately 0.15% to 0.55% of the patients suffering with acute pulmonary embolism develop chronic thromboembolic pulmonary hypertension. Due to non-specific symptoms observed in chronic thromboembolic pulmonary hypertension its diagnosis is complex. However, some of the prominent symptoms of chronic thromboembolic pulmonary hypertension are chest discomfort, breathlessness and fatigue. Chronic thromboembolic pulmonary hypertension market can be segmented on the basis of types of diagnosis such as transthoracic echocardiogram (TTE), ventilation-perfusion (V/Q) scan, pulmonary angiography, heart catheterization, computed tomography (CT) pulmonary angiography and other pulmonary function tests.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Chronic Thromboembolic Pulmonary Hypertension industry chain, the market status of Hospitals (Transthoracic Echocardiogram (TTE), Ventilation-Perfusion (V/Q) Scan), Ambulatory Surgical Centers (Transthoracic Echocardiogram (TTE), Ventilation-Perfusion (V/Q) Scan), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Chronic Thromboembolic Pulmonary Hypertension.
Regionally, the report analyzes the Chronic Thromboembolic Pulmonary Hypertension markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Chronic Thromboembolic Pulmonary Hypertension market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Chronic Thromboembolic Pulmonary Hypertension market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Chronic Thromboembolic Pulmonary Hypertension industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Transthoracic Echocardiogram (TTE), Ventilation-Perfusion (V/Q) Scan).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Chronic Thromboembolic Pulmonary Hypertension market.
Regional Analysis: The report involves examining the Chronic Thromboembolic Pulmonary Hypertension market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Chronic Thromboembolic Pulmonary Hypertension market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Chronic Thromboembolic Pulmonary Hypertension:
Company Analysis: Report covers individual Chronic Thromboembolic Pulmonary Hypertension players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Chronic Thromboembolic Pulmonary Hypertension This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).
Technology Analysis: Report covers specific technologies relevant to Chronic Thromboembolic Pulmonary Hypertension. It assesses the current state, advancements, and potential future developments in Chronic Thromboembolic Pulmonary Hypertension areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Chronic Thromboembolic Pulmonary Hypertension market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Chronic Thromboembolic Pulmonary Hypertension market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Transthoracic Echocardiogram (TTE)
Ventilation-Perfusion (V/Q) Scan
Pulmonary Angiography
Heart Catheterization
Computed Tomography (CT) Pulmonary Angiography
Others
Market segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Market segment by players, this report covers
Bayer
Johnson & Johnson
Nippon Shinyaku
GlaxoSmithKline
Sun Pharmaceutical Industries
Scipharm SaRL
Promedica International
Medical Research Network
Gilead Sciences
Daiichi Sankyo
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chronic Thromboembolic Pulmonary Hypertension product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chronic Thromboembolic Pulmonary Hypertension, with revenue, gross margin and global market share of Chronic Thromboembolic Pulmonary Hypertension from 2019 to 2024.
Chapter 3, the Chronic Thromboembolic Pulmonary Hypertension competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Chronic Thromboembolic Pulmonary Hypertension market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Thromboembolic Pulmonary Hypertension.
Chapter 13, to describe Chronic Thromboembolic Pulmonary Hypertension research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Chronic Thromboembolic Pulmonary Hypertension
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Chronic Thromboembolic Pulmonary Hypertension by Type
    • 1.3.1 Overview: Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Chronic Thromboembolic Pulmonary Hypertension Consumption Value Market Share by Type in 2023
    • 1.3.3 Transthoracic Echocardiogram (TTE)
    • 1.3.4 Ventilation-Perfusion (V/Q) Scan
    • 1.3.5 Pulmonary Angiography
    • 1.3.6 Heart Catheterization
    • 1.3.7 Computed Tomography (CT) Pulmonary Angiography
    • 1.3.8 Others
  • 1.4 Global Chronic Thromboembolic Pulmonary Hypertension Market by Application
    • 1.4.1 Overview: Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Ambulatory Surgical Centers
    • 1.4.4 Others
  • 1.5 Global Chronic Thromboembolic Pulmonary Hypertension Market Size & Forecast
  • 1.6 Global Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast by Region
    • 1.6.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Region, (2019-2030)
    • 1.6.3 North America Chronic Thromboembolic Pulmonary Hypertension Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Chronic Thromboembolic Pulmonary Hypertension Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size and Prospect (2019-2030)
    • 1.6.6 South America Chronic Thromboembolic Pulmonary Hypertension Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Chronic Thromboembolic Pulmonary Hypertension Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer Chronic Thromboembolic Pulmonary Hypertension Product and Solutions
    • 2.1.4 Bayer Chronic Thromboembolic Pulmonary Hypertension Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bayer Recent Developments and Future Plans
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Chronic Thromboembolic Pulmonary Hypertension Product and Solutions
    • 2.2.4 Johnson & Johnson Chronic Thromboembolic Pulmonary Hypertension Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.3 Nippon Shinyaku
    • 2.3.1 Nippon Shinyaku Details
    • 2.3.2 Nippon Shinyaku Major Business
    • 2.3.3 Nippon Shinyaku Chronic Thromboembolic Pulmonary Hypertension Product and Solutions
    • 2.3.4 Nippon Shinyaku Chronic Thromboembolic Pulmonary Hypertension Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Nippon Shinyaku Recent Developments and Future Plans
  • 2.4 GlaxoSmithKline
    • 2.4.1 GlaxoSmithKline Details
    • 2.4.2 GlaxoSmithKline Major Business
    • 2.4.3 GlaxoSmithKline Chronic Thromboembolic Pulmonary Hypertension Product and Solutions
    • 2.4.4 GlaxoSmithKline Chronic Thromboembolic Pulmonary Hypertension Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.5 Sun Pharmaceutical Industries
    • 2.5.1 Sun Pharmaceutical Industries Details
    • 2.5.2 Sun Pharmaceutical Industries Major Business
    • 2.5.3 Sun Pharmaceutical Industries Chronic Thromboembolic Pulmonary Hypertension Product and Solutions
    • 2.5.4 Sun Pharmaceutical Industries Chronic Thromboembolic Pulmonary Hypertension Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sun Pharmaceutical Industries Recent Developments and Future Plans
  • 2.6 Scipharm SaRL
    • 2.6.1 Scipharm SaRL Details
    • 2.6.2 Scipharm SaRL Major Business
    • 2.6.3 Scipharm SaRL Chronic Thromboembolic Pulmonary Hypertension Product and Solutions
    • 2.6.4 Scipharm SaRL Chronic Thromboembolic Pulmonary Hypertension Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Scipharm SaRL Recent Developments and Future Plans
  • 2.7 Promedica International
    • 2.7.1 Promedica International Details
    • 2.7.2 Promedica International Major Business
    • 2.7.3 Promedica International Chronic Thromboembolic Pulmonary Hypertension Product and Solutions
    • 2.7.4 Promedica International Chronic Thromboembolic Pulmonary Hypertension Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Promedica International Recent Developments and Future Plans
  • 2.8 Medical Research Network
    • 2.8.1 Medical Research Network Details
    • 2.8.2 Medical Research Network Major Business
    • 2.8.3 Medical Research Network Chronic Thromboembolic Pulmonary Hypertension Product and Solutions
    • 2.8.4 Medical Research Network Chronic Thromboembolic Pulmonary Hypertension Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Medical Research Network Recent Developments and Future Plans
  • 2.9 Gilead Sciences
    • 2.9.1 Gilead Sciences Details
    • 2.9.2 Gilead Sciences Major Business
    • 2.9.3 Gilead Sciences Chronic Thromboembolic Pulmonary Hypertension Product and Solutions
    • 2.9.4 Gilead Sciences Chronic Thromboembolic Pulmonary Hypertension Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Gilead Sciences Recent Developments and Future Plans
  • 2.10 Daiichi Sankyo
    • 2.10.1 Daiichi Sankyo Details
    • 2.10.2 Daiichi Sankyo Major Business
    • 2.10.3 Daiichi Sankyo Chronic Thromboembolic Pulmonary Hypertension Product and Solutions
    • 2.10.4 Daiichi Sankyo Chronic Thromboembolic Pulmonary Hypertension Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Daiichi Sankyo Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Chronic Thromboembolic Pulmonary Hypertension Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Chronic Thromboembolic Pulmonary Hypertension by Company Revenue
    • 3.2.2 Top 3 Chronic Thromboembolic Pulmonary Hypertension Players Market Share in 2023
    • 3.2.3 Top 6 Chronic Thromboembolic Pulmonary Hypertension Players Market Share in 2023
  • 3.3 Chronic Thromboembolic Pulmonary Hypertension Market: Overall Company Footprint Analysis
    • 3.3.1 Chronic Thromboembolic Pulmonary Hypertension Market: Region Footprint
    • 3.3.2 Chronic Thromboembolic Pulmonary Hypertension Market: Company Product Type Footprint
    • 3.3.3 Chronic Thromboembolic Pulmonary Hypertension Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Chronic Thromboembolic Pulmonary Hypertension Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Chronic Thromboembolic Pulmonary Hypertension Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Chronic Thromboembolic Pulmonary Hypertension Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Chronic Thromboembolic Pulmonary Hypertension Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Type (2019-2030)
  • 6.2 North America Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Application (2019-2030)
  • 6.3 North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country
    • 6.3.1 North America Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Country (2019-2030)
    • 6.3.2 United States Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Type (2019-2030)
  • 7.2 Europe Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Application (2019-2030)
  • 7.3 Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country
    • 7.3.1 Europe Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 7.3.3 France Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region
    • 8.3.1 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Region (2019-2030)
    • 8.3.2 China Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 8.3.5 India Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Type (2019-2030)
  • 9.2 South America Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Application (2019-2030)
  • 9.3 South America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country
    • 9.3.1 South America Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Country
    • 10.3.1 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Chronic Thromboembolic Pulmonary Hypertension Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Chronic Thromboembolic Pulmonary Hypertension Market Drivers
  • 11.2 Chronic Thromboembolic Pulmonary Hypertension Market Restraints
  • 11.3 Chronic Thromboembolic Pulmonary Hypertension Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Chronic Thromboembolic Pulmonary Hypertension Industry Chain
  • 12.2 Chronic Thromboembolic Pulmonary Hypertension Upstream Analysis
  • 12.3 Chronic Thromboembolic Pulmonary Hypertension Midstream Analysis
  • 12.4 Chronic Thromboembolic Pulmonary Hypertension Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Chronic Thromboembolic Pulmonary Hypertension. Industry analysis & Market Report on Chronic Thromboembolic Pulmonary Hypertension is a syndicated market report, published as Global Chronic Thromboembolic Pulmonary Hypertension Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Chronic Thromboembolic Pulmonary Hypertension market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo